In pancreatic cancer, CXCR4 overexpression is a prognostic factor of poor OS; CXCR4 blocking significantly mediates the phenotype of pancreatic cancer cells, inhibiting tumor cell proliferation, invasion, and metastasis [12]. This evidence concerns the gene CXCR4 and familial pancreatic carcinoma.